Philosophy of Cancer Theranostics
Imagine a theranostic nuclear physician oncologist engaged in a Socratic philosophic dialogue. Questions that may be posed include the status of our current knowledge base of radiomolecular tumor biology, the meaning of precision in personalized dosimetry, the nature of responsibility for direct pat...
Gespeichert in:
| Veröffentlicht in: | Cancer biotherapy & radiopharmaceuticals 2023-02, Vol.38 (1), p.1-7 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Cancer biotherapy & radiopharmaceuticals |
| container_volume | 38 |
| creator | Turner, J Harvey |
| description | Imagine a theranostic nuclear physician oncologist engaged in a Socratic philosophic dialogue. Questions that may be posed include the status of our current knowledge base of radiomolecular tumor biology, the meaning of precision in personalized dosimetry, the nature of responsibility for direct patient care, and the moral and ethical dimensions of individual quality of life (QOL) when survival is prolonged. This review invites reflective enquiry into one's personal practice of theranostics in cancer care, with the objective of optimizing clinical outcomes, not only in terms of prolonged survival but also individual QOL, in respect of its meaning for each patient, both physically and emotionally. |
| doi_str_mv | 10.1089/cbr.2022.0082 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2753305421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2753305421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c223t-bc3bc2083076273c3d55a68c4b4a9db5bb729a61428e170bc35acb78c4dc7a3f3</originalsourceid><addsrcrecordid>eNqF0D1PwzAUhWELgWgpjKyobCwJ19dx7IyoKh9SJRjKbNmOowalcbHTof8eRy2sTL6yHp3hJeSWQk5BVo_WhBwBMQeQeEamlHORScnxPN0gi6wSkk_IVYxfAFBCKS7JhJVFxZjgU3L_sWk7H_1uc5j7Zr7QvXVhvt64oHsfh9bGa3LR6C66m9M7I5_Py_XiNVu9v7wtnlaZRWRDZiwzFkEyECUKZlnNuS6lLUyhq9pwYwRWuqQFSkcFJM61NSKB2grNGjYjD8fdXfDfexcHtW2jdV2ne-f3UaHgjAEvkCaaHakNPsbgGrUL7VaHg6KgxioqVVFjFTVWSf7uNL03W1f_6d8MCbAjGL9133etMy4M_8z-AHe1bR0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753305421</pqid></control><display><type>article</type><title>Philosophy of Cancer Theranostics</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Turner, J Harvey</creator><creatorcontrib>Turner, J Harvey</creatorcontrib><description>Imagine a theranostic nuclear physician oncologist engaged in a Socratic philosophic dialogue. Questions that may be posed include the status of our current knowledge base of radiomolecular tumor biology, the meaning of precision in personalized dosimetry, the nature of responsibility for direct patient care, and the moral and ethical dimensions of individual quality of life (QOL) when survival is prolonged. This review invites reflective enquiry into one's personal practice of theranostics in cancer care, with the objective of optimizing clinical outcomes, not only in terms of prolonged survival but also individual QOL, in respect of its meaning for each patient, both physically and emotionally.</description><identifier>ISSN: 1084-9785</identifier><identifier>EISSN: 1557-8852</identifier><identifier>DOI: 10.1089/cbr.2022.0082</identifier><identifier>PMID: 36493375</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc., publishers</publisher><subject>Humans ; Invited Update ; Neoplasms - diagnosis ; Neoplasms - radiotherapy ; Philosophy ; Precision Medicine ; Quality of Life</subject><ispartof>Cancer biotherapy & radiopharmaceuticals, 2023-02, Vol.38 (1), p.1-7</ispartof><rights>2023, Mary Ann Liebert, Inc., publishers</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c223t-bc3bc2083076273c3d55a68c4b4a9db5bb729a61428e170bc35acb78c4dc7a3f3</cites><orcidid>0000-0002-5254-9914</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36493375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turner, J Harvey</creatorcontrib><title>Philosophy of Cancer Theranostics</title><title>Cancer biotherapy & radiopharmaceuticals</title><addtitle>Cancer Biother Radiopharm</addtitle><description>Imagine a theranostic nuclear physician oncologist engaged in a Socratic philosophic dialogue. Questions that may be posed include the status of our current knowledge base of radiomolecular tumor biology, the meaning of precision in personalized dosimetry, the nature of responsibility for direct patient care, and the moral and ethical dimensions of individual quality of life (QOL) when survival is prolonged. This review invites reflective enquiry into one's personal practice of theranostics in cancer care, with the objective of optimizing clinical outcomes, not only in terms of prolonged survival but also individual QOL, in respect of its meaning for each patient, both physically and emotionally.</description><subject>Humans</subject><subject>Invited Update</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - radiotherapy</subject><subject>Philosophy</subject><subject>Precision Medicine</subject><subject>Quality of Life</subject><issn>1084-9785</issn><issn>1557-8852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0D1PwzAUhWELgWgpjKyobCwJ19dx7IyoKh9SJRjKbNmOowalcbHTof8eRy2sTL6yHp3hJeSWQk5BVo_WhBwBMQeQeEamlHORScnxPN0gi6wSkk_IVYxfAFBCKS7JhJVFxZjgU3L_sWk7H_1uc5j7Zr7QvXVhvt64oHsfh9bGa3LR6C66m9M7I5_Py_XiNVu9v7wtnlaZRWRDZiwzFkEyECUKZlnNuS6lLUyhq9pwYwRWuqQFSkcFJM61NSKB2grNGjYjD8fdXfDfexcHtW2jdV2ne-f3UaHgjAEvkCaaHakNPsbgGrUL7VaHg6KgxioqVVFjFTVWSf7uNL03W1f_6d8MCbAjGL9133etMy4M_8z-AHe1bR0</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Turner, J Harvey</creator><general>Mary Ann Liebert, Inc., publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5254-9914</orcidid></search><sort><creationdate>20230201</creationdate><title>Philosophy of Cancer Theranostics</title><author>Turner, J Harvey</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c223t-bc3bc2083076273c3d55a68c4b4a9db5bb729a61428e170bc35acb78c4dc7a3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Humans</topic><topic>Invited Update</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - radiotherapy</topic><topic>Philosophy</topic><topic>Precision Medicine</topic><topic>Quality of Life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turner, J Harvey</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer biotherapy & radiopharmaceuticals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turner, J Harvey</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Philosophy of Cancer Theranostics</atitle><jtitle>Cancer biotherapy & radiopharmaceuticals</jtitle><addtitle>Cancer Biother Radiopharm</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>38</volume><issue>1</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>1084-9785</issn><eissn>1557-8852</eissn><abstract>Imagine a theranostic nuclear physician oncologist engaged in a Socratic philosophic dialogue. Questions that may be posed include the status of our current knowledge base of radiomolecular tumor biology, the meaning of precision in personalized dosimetry, the nature of responsibility for direct patient care, and the moral and ethical dimensions of individual quality of life (QOL) when survival is prolonged. This review invites reflective enquiry into one's personal practice of theranostics in cancer care, with the objective of optimizing clinical outcomes, not only in terms of prolonged survival but also individual QOL, in respect of its meaning for each patient, both physically and emotionally.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc., publishers</pub><pmid>36493375</pmid><doi>10.1089/cbr.2022.0082</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-5254-9914</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1084-9785 |
| ispartof | Cancer biotherapy & radiopharmaceuticals, 2023-02, Vol.38 (1), p.1-7 |
| issn | 1084-9785 1557-8852 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2753305421 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Humans Invited Update Neoplasms - diagnosis Neoplasms - radiotherapy Philosophy Precision Medicine Quality of Life |
| title | Philosophy of Cancer Theranostics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T14%3A12%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Philosophy%20of%20Cancer%20Theranostics&rft.jtitle=Cancer%20biotherapy%20&%20radiopharmaceuticals&rft.au=Turner,%20J%20Harvey&rft.date=2023-02-01&rft.volume=38&rft.issue=1&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=1084-9785&rft.eissn=1557-8852&rft_id=info:doi/10.1089/cbr.2022.0082&rft_dat=%3Cproquest_cross%3E2753305421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2753305421&rft_id=info:pmid/36493375&rfr_iscdi=true |